SG11201502635SA - Immunogenic composition - Google Patents

Immunogenic composition

Info

Publication number: SG11201502635SA
Authority: SG; Singapore
Prior art keywords: immunogenic composition; immunogenic; composition
Prior art date: 2012-10-17

Application number

SG11201502635SA

Inventor

Vincent Verlant

Original Assignee

Glaxosmithkline Biolog Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-10-17

Filing date

2013-10-15

Publication date

2015-05-28

2012-10-17 Priority claimed from GBGB1218660.7A external-priority patent/GB201218660D0/en

2013-03-14 Priority claimed from US13/826,932 external-priority patent/US20140193451A1/en

2013-03-14 Priority claimed from US13/827,203 external-priority patent/US20140105927A1/en

2013-10-15 Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa

2015-05-28 Publication of SG11201502635SA publication Critical patent/SG11201502635SA/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/08—Clostridium, e.g. Clostridium tetani
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/099—Bordetella
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Mycology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
AIDS & HIV (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Tropical Medicine & Parasitology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Ophthalmology & Optometry (AREA)
Hematology (AREA)
Rheumatology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)

SG11201502635SA 2012-10-17 2013-10-15 Immunogenic composition SG11201502635SA (en)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US201261714942P	2012-10-17	2012-10-17
US201261714956P	2012-10-17	2012-10-17
GBGB1218660.7A GB201218660D0 (en)	2012-10-17	2012-10-17	Immunogenic composition
US13/826,696 US9561268B2 (en)	2012-10-17	2013-03-14	Immunogenic composition
US13/826,932 US20140193451A1 (en)	2012-10-17	2013-03-14	Immunogenic composition
US13/827,203 US20140105927A1 (en)	2012-10-17	2013-03-14	Immunogenic composition
PCT/EP2013/071477 WO2014060385A1 (en)	2012-10-17	2013-10-15	Immunogenic composition

Publications (1)

Publication Number	Publication Date
SG11201502635SA true SG11201502635SA (en)	2015-05-28

Family

ID=53008966

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SG11201502635SA SG11201502635SA (en)	2012-10-17	2013-10-15	Immunogenic composition
SG11201502634TA SG11201502634TA (en)	2012-10-17	2013-10-15	Immunogenic composition comprising 1 or more streptococcus pneumoniae capsular saccharide conjugates and a protein component comprising protein e and/or pila fromhaemophilus influenzae.

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SG11201502634TA SG11201502634TA (en)	2012-10-17	2013-10-15	Immunogenic composition comprising 1 or more streptococcus pneumoniae capsular saccharide conjugates and a protein component comprising protein e and/or pila fromhaemophilus influenzae.

Country Status (13)

Country	Link
EP (3)	EP2908856B1 (en)
JP (3)	JP6412500B2 (en)
KR (2)	KR20150072444A (en)
CN (2)	CN104968366B (en)
AU (2)	AU2013331781A1 (en)
BR (3)	BR112015008417A8 (en)
CA (3)	CA2888321A1 (en)
EA (2)	EA201590490A1 (en)
ES (1)	ES2640320T3 (en)
IL (2)	IL238053A0 (en)
MX (2)	MX365842B (en)
SG (2)	SG11201502635SA (en)
WO (3)	WO2014060383A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB201218660D0 (en)	2012-10-17	2012-11-28	Glaxosmithkline Biolog Sa	Immunogenic composition
US11160855B2 (en)	2014-01-21	2021-11-02	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
CN104306965B (en) *	2014-10-31	2017-05-10	康希诺生物股份公司	Immunogenic composition for preventing streptococcus pneumoniae infectious diseases and preparation method thereof
IL303998A (en) *	2015-07-21	2023-08-01	Pfizer	Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
GB201518684D0 (en) *	2015-10-21	2015-12-02	Glaxosmithkline Biolog Sa	Vaccine
GB201603029D0 (en) *	2016-02-22	2016-04-06	Glaxosmithkline Biolog Sa	Vaccine
CN106432512B (en) *	2016-09-30	2022-03-01	康希诺生物股份公司	Protein carrier for enhancing polysaccharide antigen immunogenicity and preparation method and application thereof
JP7446227B2 (en) *	2018-01-19	2024-03-08	オービーアイファーマ，インコーポレイテッド	CRM197 protein expression method
CN110540597B (en) *	2018-12-20	2021-04-30	湖北工业大学	Preparation method of latex microsphere immunochromatographic test paper based on haemophilus influenzae surface protein
MX2022013456A (en) *	2020-05-01	2022-11-16	Sinocelltech Ltd	Method for improving immunogenicity of protein/peptide antigen.
KR20220142219A (en) *	2021-04-14	2022-10-21	한국생명공학연구원	Signal sequences for inducing secretion of proteins in intestinal microorganism
EP4169513A1 (en)	2021-10-19	2023-04-26	GlaxoSmithKline Biologicals S.A.	Adjuvant composition comprising sting agonists
CN117512031B (en) *	2023-10-16	2024-06-25	江苏金迪克生物技术股份有限公司	Purification method of pneumococcal capsular polysaccharide

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000056359A2 (en) *	1999-03-19	2000-09-28	Smithkline Beecham Biologicals S.A.	Vaccine against streptococcus pneumoniae
GB0108364D0 (en) *	2001-04-03	2001-05-23	Glaxosmithkline Biolog Sa	Vaccine composition
SI1296715T2 (en) *	2000-06-29	2016-03-31	Smithkline Beecham Biologicals S.A.	Multivalent vaccine composition
GB0022742D0 (en) *	2000-09-15	2000-11-01	Smithkline Beecham Biolog	Vaccine
GB0130215D0 (en) *	2001-12-18	2002-02-06	Glaxosmithkline Biolog Sa	Vaccine
SI2192127T1 (en) *	2003-12-23	2012-10-30	Nationwide Children S Hospital Inc	Haemophilus influenzae type IV Pili
EP2298794A3 (en) *	2005-07-08	2011-04-06	Nationwide Children's Hospital, Inc.	Chimeric vaccine for haemophilus influenzae-induced disease
CA2636566C (en) *	2006-01-17	2018-03-13	Arne Forsgren	A novel surface exposed haemophilus influenzae protein (protein e; pe)
KR101579947B1 (en) *	2007-06-26	2015-12-28	글락소스미스클라인 바이오로지칼즈 에스.에이.	Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
CA2748149C (en) *	2008-12-24	2018-03-06	Netherlands Vaccine Institute	Modified steptococcus pneumonia pneumolysin (ply) polypeptides
KR101512053B1 (en) *	2009-09-03	2015-04-28	화이자 백신스 엘엘씨	Pcsk9 vaccine
JP5894083B2 (en) *	2009-12-22	2016-03-23	サノフィパストゥールリミテッドＳａｎｏｆｉＰａｓｔｅｕｒＬｉｍｉｔｅｄ	Immunogenic composition
JP6046632B2 (en) *	2010-12-03	2016-12-21	サノフィパストゥールリミテッドＳａｎｏｆｉＰａｓｔｅｕｒＬｉｍｉｔｅｄ	Composition for immunization against pneumococci
JP5944480B2 (en) *	2011-03-22	2016-07-05	セルム・インスティテュート・オブ・インディア・ピーブイティー．・リミテッド	A novel method for preparing polysaccharides
TW201302779A (en) *	2011-04-13	2013-01-16	Glaxosmithkline Biolog Sa	Fusion protein and combination vaccine
AU2012257771C1 (en) *	2011-05-17	2015-12-03	Glaxosmithkline Biologicals S.A.	Vaccine against Streptococcus pneumoniae

2013
- 2013-10-15 CN CN201380066162.9A patent/CN104968366B/en active Active
- 2013-10-15 SG SG11201502635SA patent/SG11201502635SA/en unknown
- 2013-10-15 BR BR112015008417A patent/BR112015008417A8/en not_active Application Discontinuation
- 2013-10-15 EA EA201590490A patent/EA201590490A1/en unknown
- 2013-10-15 WO PCT/EP2013/071472 patent/WO2014060383A1/en not_active Ceased
- 2013-10-15 JP JP2015537218A patent/JP6412500B2/en not_active Expired - Fee Related
- 2013-10-15 KR KR1020157013039A patent/KR20150072444A/en not_active Withdrawn
- 2013-10-15 AU AU2013331781A patent/AU2013331781A1/en not_active Abandoned
- 2013-10-15 CA CA2888321A patent/CA2888321A1/en not_active Abandoned
- 2013-10-15 MX MX2015004949A patent/MX365842B/en active IP Right Grant
- 2013-10-15 EP EP13779191.9A patent/EP2908856B1/en active Active
- 2013-10-15 JP JP2015537220A patent/JP2015534964A/en active Pending
- 2013-10-15 EP EP13776808.1A patent/EP2908854A2/en not_active Ceased
- 2013-10-15 JP JP2015537216A patent/JP6236086B2/en active Active
- 2013-10-15 WO PCT/EP2013/071477 patent/WO2014060385A1/en not_active Ceased
- 2013-10-15 WO PCT/EP2013/071483 patent/WO2014060389A2/en not_active Ceased
- 2013-10-15 SG SG11201502634TA patent/SG11201502634TA/en unknown
- 2013-10-15 CA CA2888310A patent/CA2888310C/en active Active
- 2013-10-15 BR BR112015008418A patent/BR112015008418A2/en not_active IP Right Cessation
- 2013-10-15 EP EP13779190.1A patent/EP2908855B1/en active Active
- 2013-10-15 ES ES13779190.1T patent/ES2640320T3/en active Active
- 2013-10-15 EA EA201590491A patent/EA201590491A1/en unknown
- 2013-10-15 CN CN201380066113.5A patent/CN104853768B/en not_active Expired - Fee Related
- 2013-10-15 MX MX2015005002A patent/MX2015005002A/en unknown
- 2013-10-15 KR KR1020157013037A patent/KR20150058571A/en not_active Withdrawn
- 2013-10-15 AU AU2013333975A patent/AU2013333975A1/en not_active Abandoned
- 2013-10-15 CA CA2888300A patent/CA2888300A1/en not_active Abandoned
- 2013-10-15 BR BR112015008419-2A patent/BR112015008419B1/en active IP Right Grant
2015
- 2015-03-31 IL IL238053A patent/IL238053A0/en unknown
- 2015-04-01 IL IL238079A patent/IL238079A0/en unknown

Also Published As

Publication number	Publication date
CA2888300A1 (en)	2014-04-24
CN104853768A (en)	2015-08-19
JP2015534964A (en)	2015-12-07
CA2888310C (en)	2021-07-06
CA2888321A1 (en)	2014-04-24
IL238079A0 (en)	2015-05-31
WO2014060389A2 (en)	2014-04-24
EP2908856A1 (en)	2015-08-26
MX2015004949A (en)	2015-07-06
BR112015008418A2 (en)	2017-07-04
WO2014060389A3 (en)	2014-09-12
CN104968366A (en)	2015-10-07
WO2014060383A1 (en)	2014-04-24
JP6412500B2 (en)	2018-10-24
BR112015008419A8 (en)	2019-09-10
AU2013331781A1 (en)	2015-05-07
JP2015536312A (en)	2015-12-21
EP2908854A2 (en)	2015-08-26
SG11201502634TA (en)	2015-05-28
BR112015008419A2 (en)	2017-07-04
AU2013331781A8 (en)	2015-05-14
AU2013333975A1 (en)	2015-05-07
WO2014060385A1 (en)	2014-04-24
BR112015008417A8 (en)	2019-09-10
BR112015008419B1 (en)	2022-11-08
JP2015534962A (en)	2015-12-07
EP2908855B1 (en)	2017-06-28
EA201590490A1 (en)	2015-10-30
EA201590491A1 (en)	2016-01-29
BR112015008417A2 (en)	2017-07-04
CA2888310A1 (en)	2014-04-24
KR20150072444A (en)	2015-06-29
IL238053A0 (en)	2015-05-31
JP6236086B2 (en)	2017-11-22
ES2640320T3 (en)	2017-11-02
CN104853768B (en)	2019-04-19
MX365842B (en)	2019-06-17
MX2015005002A (en)	2015-07-17
EP2908856B1 (en)	2019-02-20
CN104968366B (en)	2017-12-01
EP2908855A1 (en)	2015-08-26
KR20150058571A (en)	2015-05-28

Publication	Publication Date	Title
ZA201503927B (en)	2017-11-29	Immunogenic composition
SG11201404447WA (en)	2014-08-28	Immunogenic composition
PL2647387T3 (en)	2016-09-30	Vaccine Composition
SG10201912291YA (en)	2020-02-27	Vaccine compositions
IL238079A0 (en)	2015-05-31	Immunogenic composition
GB201200707D0 (en)	2012-02-29	Composition
SG10201702685WA (en)	2017-04-27	Immunogenic composition
GB201223342D0 (en)	2013-02-06	Immunogenic composition
PT2714910T (en)	2018-03-09	Immunogenic composition
EP2878295A4 (en)	2015-12-23	Composition
GB201218660D0 (en)	2012-11-28	Immunogenic composition
EP2910537A4 (en)	2016-06-29	Gas-generating-agent composition
GB201204968D0 (en)	2012-05-02	Immunogenic composition
GB201204851D0 (en)	2012-05-02	Immunogenic composition
GB201202695D0 (en)	2012-04-04	Composition